Alchemia Ltd Shares Rise 20% on Lung Cancer Trial Update

Alchemia Ltd. shares rose 20% in Sydney trading after the company said its HA-Irinotecan product showed promising results in its first two small cell lung cancer patients reporting substantial shinkage of their tumors after 10 days.

To contact the editor responsible for this story: Rebecca Evans at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.